Stock GDTC CYTOMED THERAPEUTICS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus CytoMed Therapeutics Limited

Equities

GDTC

SGXZ17669631

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-05-23 EDT 		5-day change 1st Jan Change
2.02 USD -1.94% Intraday chart for CytoMed Therapeutics Limited -10.42% -58.78%
04-22 CytoMed Therapeutics Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
04-14 Certain Ordinary Shares of CytoMed Therapeutics Limited are subject to a Lock-Up Agreement Ending on 14-APR-2024. CI

Evolution of the average Target Price on CytoMed Therapeutics Limited

Price target over the last 5 years

History of analyst recommendation changes

c7ce99a332c270da8024d9a1a.mJx9CVpdZJAMMTy9riujLgk4LFVsBEHDzMMiWohHTQk.06QVOTAHE_JiWXPE9H7iW2pBbyM0WzSM-KFIFbF1ITHc6x5haDtW2VhieQ~18f62e77caf89201d57b5e5abb659b59

Analyst Recommendations on CytoMed Therapeutics Limited

Benchmark Starts CytoMed Therapeutics at Speculative Buy With $5 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.06 USD
Average target price
5 USD
Spread / Average Target
+142.72%
High Price Target
5 USD
Spread / Highest target
+142.72%
Low Price Target
5 USD
Spread / Lowest Target
+142.72%

Consensus detail

Consensus revision (last 18 months)

Analysts covering CytoMed Therapeutics Limited

Benchmark Company

Ratings for CytoMed Therapeutics Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. GDTC Stock
  4. Consensus CytoMed Therapeutics Limited